MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cartesian Therapeutics (RNAC) Earnings Date & Reports

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RNAC is expected to report earnings to rise 32.35% to -89 cents per share on May 09

Cartesian Therapeutics RNAC Stock Earnings Reports
Q1'24
Est.
$-0.90
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.48
Q4'23
Missed
by $1.47
Q3'23
Missed
by $1.28
The last earnings report on May 08 showed earnings per share of -68 cents, missing the estimate of -67 cents. With 300.63K shares outstanding, the current market capitalization sits at 276.02M.
View a ticker or compare two or three
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com